Prognosis of Patients with Stages I and II Non–Small Cell Lung Cancer With Nodal MicrometastasesBACKGROUND: This retrospective study aimed to determine the prognostic significance of immunohistochemically detected occult micrometastases (OM) in mediastinal lymph nodes (LN) obtained during Transcervical ...
Stage 2non-small cell lung cancer(NSCLC) is localized cancer that has not spread beyond one lung or the locallymph nodeson the same side of the chest. Any lung cancer diagnosis is serious, but being in thisearly stagemeans your disease is very treatable, and your chances for a long-term...
Survival Rates According to Clinical Stage for Non-Small Cell Lung Cancer Treated With Radiation Therapy Clinical stage llP%) All Performance If%) patients status 0-1 IIIA(%) IIIB(o/~) No. of patients Survival (yr) 1 1.5 2 3 40 72 50 35 21 62 70 50 33 20 41 389 267 83 48 42...
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved considerably, especially in the past 10 years. The systematic screeni
The article discusses research on the significance of lymph node involvement in the prognosis of stage II-N1 non-small-cell lung cancer (NSCLC). It references the study "Prognostic Significance of the Extent of Lymph Node Involvement in Stage II-N1 Non-Small Cell Lung Cancer," by Li Z. M...
The standard treatment of stage III N2 small cell lung cancer (SCLC) is concurrent chemoradiation, and surgery is not recommended. This study was aimed to evaluate whether surgery has survival benefits in patients with stage III N2 SCLC and investigate the factors influencing survival of surgery. ...
Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy foll... Survivin and smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant che...
- 《Lung Cancer》 被引量: 46发表: 1995年 Safety and prognosis of limited surgery for octogenarians with non-small-cell lung cancer s with clinical stage I non-small-cell lung cancer (NSCLC) to assess the safety and prognosis for patients who underwent radical or limited surgery. ... A ...
The 5-year survival of patients with small cell lung cancer is only 5%. The staging of small cell lung cancer is divided into limited stage and extensive stage (Box 64-3). Limited stage refers to disease that can be confined to one radiation port. At the time of presentation, ...
The influence of simple clinical and biochemical variables on prognosis has been confirmed by the analysis of very large numbers of patients. Patients with small-cell lung cancer surviving at 2 years after chemotherapy continue to be at risk for relapse for up to 5 more years independent of the...